POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (10.22.2021, 5:45pm CEST, WHO):   U.S. 74,227    India 15,786    Brazil 15,609    United Kingdom 51,484    Russia 37,141    Turkey 28,465    France 5,498    Iran 11,788    Argentina 1,218    Columbia 1,224    Italy 3,791    Germany 19,572    Mexico 5,069    Poland 5,716    Philippines 4,806    Ukraine 23,785    Malaysia 6,210    Peru 1,034    Netherlands 5,223    Iraq 1,882    Thailand 9,810    Czechia 3,638    Canada 2,641    Chile 1,793    Romania 15,410    Serbia 7,327    Kazakhstan 1,893    Cuba 1,435    Vietnam 3,636    Hungary 2,548    Austria 3,818    Greece 3,376    Georgia 4,155    Belarus 2,097    Bulgaria 4,816    Azerbaijan 2,005    Slovakia 3,470    Croatia 3,258    Ireland 2,026    Venezuela 1,254    Lithuania 3,016    Denmark 1,247    South Korea 1,440    Moldova 1,787    Slovenia 1,845    Armenia 2,146    Latvia 3,133    Estonia 1,323    China 51    Singapore 3,439    New Zealand 134    Australia 2,643   

Life expectancy hits 73.4 years and will reach 80, says WHO

October 22, 2021
Life expectancy has increased to 73.4 years, said the World Health Organisation (WHO) in a new report.

Trending now

Life expectancy hits 73.4 years and will reach 80, says WHO

Russia reports new COVID variant maybe more contagious than Delta, Putin declares non working days


Russia reports new COVID variant maybe more contagious than Delta, Putin declares non working days

October 21, 2021
Russia has reported some COVID-19 infections with a new coronavirus variant believed to be even more contagious than the Delta one, the RIA agency says.

BioVaxys files U.S. patent application for pan sarbecovirus vaccine

October 21, 2021
BioVaxys Technology announced that it has filed with the United States Patent and Trademark Office ("USPTO") a provisional patent application for its haptenized viral antigen vaccine platform to elicit a broad cross reactive immune response against most or all sarbecoviruses, the family of Coronaviruses that includes SARS-CoV-2, which causes Covid-19.

U.S. approves new booster of COVID-19 vaccines, 'mix and match' dose

October 21, 2021
The U.S. Food and Drug Administration (FDA) on Wednesday authorized COVID-19 booster doses of Moderna and Johnson and Johnson, and approved "mix and match" booster dose for currently available approved COVID-19 vaccines.

U.S. readies plan to vaccinate kids ages 5-11 against COVID-19

October 20, 2021
The Biden Administration is announcing a plan to ensure that, if a vaccine is authorized for children ages 5-11, it is quickly distributed and made conveniently and equitably available to families across the country.

Sahpra not to approve Sputnik V Covid-19 vaccine for use in South Africa

October 20, 2021
The Chairperson for Portfolio Committee on Health, Dr Kenneth Jacobs, has noted the South African Health Products Regulatory Authority’s (Sahpra’s) decision not to approve Russia’s Sputnik V Covid-19 vaccine for use in South Africa.

Immune Biosolutions begins Phase I clinical trial stages for its inhaled immunotherapy treatment

October 20, 2021
Québec based Immune Biosolutions announces the start of Phase I clinical trial for its immunotherapy (IBIO123) treatment, whose antibodies have the potential to neutralize and eliminate COVID-19 and its variants.

French study: Surgical masks still effective after 10 washes

October 19, 2021
Disposable surgical face masks that are usually considered to be single use maintain a high level of efficiency even after being washed up to 10 times, a new study by a consortium of French scientists has found.

Valneva says its COVID-19 vaccine triggers significantly stronger immune response

October 19, 2021
Valneva SE announced positive topline results from the Phase 3 pivotal trial Cov-Compare of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.

EMA starts evaluating use of COVID-19 vaccine Comirnaty in children aged 5 to 11

October 19, 2021
EMA has started evaluating an application to extend the use of BioNTech/ fizer’s COVID-19 vaccine, Comirnaty, to children aged 5 to 11.
<< < 1 2 3 4 5 ... >>